C-MER Medical Holdings (HKSE:03309) EV-to-EBITDA : -41.45 (As of May. 25, 2025)

C-MER Medical Holdings EV-to-EBITDA Chart

C-MER Medical Holdings Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBITDA		Get a 7-Day Free Trial					49.67	42.25	26.06	11.76	9.35

C-MER Medical Holdings Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-EBITDA	Get a 7-Day Free Trial															26.06	-	11.76	-	9.35

Competitive Comparison of C-MER Medical Holdings's EV-to-EBITDA

For the Medical Care Facilities subindustry, C-MER Medical Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C-MER Medical Holdings's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, C-MER Medical Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where C-MER Medical Holdings's EV-to-EBITDA falls into.

C-MER Medical Holdings EV-to-EBITDA Calculation

C-MER Medical Holdings's EV-to-EBITDA for today is calculated as:

C-MER Medical Holdings's current Enterprise Value is HK$2,179 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. C-MER Medical Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C-MER Medical Holdings  (HKSE:03309) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

C-MER Medical Holdings's PE Ratio (TTM) for today is calculated as:

C-MER Medical Holdings's share price for today is HK$1.68.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. C-MER Medical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.109.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

C-MER Medical Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of C-MER Medical Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

C-MER Medical Holdings Business Description